BR112014018732A2 - - Google Patents
Info
- Publication number
- BR112014018732A2 BR112014018732A2 BR112014018732A BR112014018732A BR112014018732A2 BR 112014018732 A2 BR112014018732 A2 BR 112014018732A2 BR 112014018732 A BR112014018732 A BR 112014018732A BR 112014018732 A BR112014018732 A BR 112014018732A BR 112014018732 A2 BR112014018732 A2 BR 112014018732A2
- Authority
- BR
- Brazil
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261632888P | 2012-02-01 | 2012-02-01 | |
| US201261689078P | 2012-05-29 | 2012-05-29 | |
| PCT/US2013/024332 WO2013116639A1 (en) | 2012-02-01 | 2013-02-01 | Campylobacter immunogenic compositions and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112014018732A2 true BR112014018732A2 (cg-RX-API-DMAC10.html) | 2017-06-20 |
| BR112014018732A8 BR112014018732A8 (pt) | 2017-07-11 |
Family
ID=47682080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014018732A BR112014018732A8 (pt) | 2012-02-01 | 2013-02-01 | Composições imunogênicas contra campylobacter e usos das mesmas |
Country Status (5)
| Country | Link |
|---|---|
| US (4) | US9328148B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2809347A1 (cg-RX-API-DMAC10.html) |
| CN (1) | CN104159601B (cg-RX-API-DMAC10.html) |
| BR (1) | BR112014018732A8 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2013116639A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080124355A1 (en) | 2006-09-22 | 2008-05-29 | David Gordon Bermudes | Live bacterial vaccines for viral infection prophylaxis or treatment |
| EP2766388A1 (en) * | 2011-10-12 | 2014-08-20 | Møller, Niels Iversen | Peptides derived from campylobacter jejuni and their use in vaccination |
| CN104159601B (zh) | 2012-02-01 | 2017-05-24 | 代表亚利桑那大学的亚利桑那董事会 | 弯曲杆菌属免疫原性组合物及其用途 |
| US10376571B2 (en) | 2013-03-15 | 2019-08-13 | The Board Of Trustees Of The University Of Arkansas | Compositions and methods of enhancing immune responses to enteric pathogens |
| US9470684B2 (en) * | 2013-08-06 | 2016-10-18 | Techlab, Inc. | Outer membrane protein 18 as a diagnostic marker for campylobacter |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| CN110520153B (zh) | 2017-01-27 | 2024-04-02 | 佛罗里达大学研究基金公司 | 在禽类中控制肠道沙门氏菌和减少弯曲杆菌的食品安全疫苗 |
| CN110041109A (zh) * | 2019-04-22 | 2019-07-23 | 刘坚 | 一种猪粪源生物肥的制备方法 |
| CN111041017B (zh) * | 2019-12-31 | 2020-10-16 | 潍坊麦卡阿吉生物科技有限公司 | 一种壳聚糖酶突变体及其应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5436146A (en) | 1989-09-07 | 1995-07-25 | The Trustees Of Princeton University | Helper-free stocks of recombinant adeno-associated virus vectors |
| US5562909A (en) | 1993-07-12 | 1996-10-08 | Massachusetts Institute Of Technology | Phosphazene polyelectrolytes as immunoadjuvants |
| US5571531A (en) | 1994-05-18 | 1996-11-05 | Mcmaster University | Microparticle delivery system with a functionalized silicone bonded to the matrix |
| US20020168342A1 (en) | 1994-11-03 | 2002-11-14 | Cell Genesys, Inc. | Novel adenoviral vectors, packaging cell lines, recombinant adenoviruses and methods |
| US6093570A (en) | 1995-06-07 | 2000-07-25 | The University Of North Carolina At Chapel Hill | Helper virus-free AAV production |
| US6040183A (en) | 1995-06-07 | 2000-03-21 | University Of North Carloina At Chapel Hill | Helper virus-free AAV production |
| EP1007637B1 (en) | 1997-04-14 | 2004-06-30 | Cell Genesys, Inc. | Methods for increasing the efficiency of recombinant aav product |
| US20010038844A1 (en) | 1998-05-04 | 2001-11-08 | Irving Nachamkin | Methods and vaccines for protection against campylobacter infections |
| EP2380440B1 (en) | 2002-04-15 | 2016-03-09 | Washington University | Regulated attenuation of live vaccines to enhance cross protective immunogenicity |
| ES2358804T3 (es) | 2003-11-21 | 2011-05-13 | Ace Biosciences A/S | Polipéptidos de campylobacter jejuni ubicados en superficie. |
| WO2008008092A2 (en) | 2006-07-10 | 2008-01-17 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Campylobacter pilus protein, compositions and methods |
| CN104159601B (zh) * | 2012-02-01 | 2017-05-24 | 代表亚利桑那大学的亚利桑那董事会 | 弯曲杆菌属免疫原性组合物及其用途 |
-
2013
- 2013-02-01 CN CN201380012681.7A patent/CN104159601B/zh active Active
- 2013-02-01 US US14/375,365 patent/US9328148B2/en active Active
- 2013-02-01 EP EP13703508.5A patent/EP2809347A1/en not_active Withdrawn
- 2013-02-01 WO PCT/US2013/024332 patent/WO2013116639A1/en not_active Ceased
- 2013-02-01 BR BR112014018732A patent/BR112014018732A8/pt not_active Application Discontinuation
-
2016
- 2016-03-10 US US15/065,979 patent/US10030054B2/en active Active
-
2018
- 2018-07-05 US US16/027,575 patent/US10683330B2/en active Active
-
2020
- 2020-06-05 US US16/893,667 patent/US11203618B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013116639A1 (en) | 2013-08-08 |
| EP2809347A1 (en) | 2014-12-10 |
| CN104159601A (zh) | 2014-11-19 |
| US11203618B2 (en) | 2021-12-21 |
| CN104159601B (zh) | 2017-05-24 |
| BR112014018732A8 (pt) | 2017-07-11 |
| US20200317737A1 (en) | 2020-10-08 |
| US20190031725A1 (en) | 2019-01-31 |
| US20150030624A1 (en) | 2015-01-29 |
| US20160184422A1 (en) | 2016-06-30 |
| US10683330B2 (en) | 2020-06-16 |
| US10030054B2 (en) | 2018-07-24 |
| US9328148B2 (en) | 2016-05-03 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |